Catalyst Funds Management Pty LTD Third Harmonic Bio, Inc. Transaction History

Catalyst Funds Management Pty LTD

$382 Billion
Q1 2025

Shares

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Dec 17, 2024	BUY	$8.74 - $15.54 $75,164 - $133,644	8,600 New	8,600 $112 Million
Q1 2024 Dec 04, 2024	BUY	$8.6 - $11.24 $73,960 - $96,664	8,600 New	8,600 $81.2 Million

Others Institutions Holding THRD

# of Institutions

96

Shares Held

38M

Call Options Held

76.6K

Put Options Held

22.8K

Atlas Venture Life Science Advisors, LLC

10.4M
Shares

$53.6 Million
10.57% of portfolio
Orbimed Advisors LLC San Diego, CA

5.78M
Shares

$29.8 Million
0.63% of portfolio
Bml Capital Management, LLC Zionsville, IN

3.82M
Shares

$19.7 Million
10.74% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.94M
Shares

$15.1 Million
0.46% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

2.51M
Shares

$12.9 Million
2.09% of portfolio

About Third Harmonic Bio, Inc.

Ticker THRD
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,328,900
Market Cap $208M

More about THRD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.